Search
The pathway will allow the evidence generated for FDA review to support Medicare coverage decisions.
Physicians tell Dr. Amy Bucher they feel a sense of empowerment in being able to offer their patients something that, along with lifestyle changes, reduces weight, lowers the risk of diabetes and high blood pressure, and helps prevent other chronic conditions.
Ferrin Williams, PharmD MBA, chief pharmacy officer at Scripta Insights, gives insights in this Q&A.
Novo Nordisk has beaten Eli Lilly in releasing the first oral GLP-1 for weight loss in adults.
Gottlieb is known for promoting transparency, strengthening patient safety and widening consumer choice, says UnitedHealth Group.
These technologies introduce new considerations regarding safety and effectiveness across the total product life cycle.
FDA will begin notifying physicians that pregnant women should avoid taking Tylenol during pregnancy unless absolutely necessary.
Amneal Pharmaceuticals’ laboratory procedures resulted in visibly contaminated injectable medications, FDA says.
New blood needed at CDC to remove officials with conflicts of interest, bad judgment and political agendas, Kennedy says.
FDA is requiring labels featuring clearer risk information, warnings on dosing and drug interactions and treatment guidance.
